Drug Testing Locations - Abington, PA

Drug Testing in Abington, PA

Abington, Pennsylvania Statistics

In 2021, Abington, PA, in Montgomery County, reported over 150 cases of drug-related offenses.

Montgomery County's overdose death rate was 33.2 per 100,000 people in 2020, affecting towns like Abington.

Abington saw a 12% increase in youth drug use from 2019 to 2021.

Prescription opioid abuse cases in Abington, PA, were reported in 4.5% of resident surveys in 2021.

Abington, PA, participated in 23 drug take-back events in 2022, collecting over 2,000 pounds of drugs.

In Abington, PA, the local police department made 112 drug-related arrests in 2020.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Abington, PA & Drug Testing Policies

Employers in Abington, PA, are vigilant regarding drug-free workplace policies. Many businesses implement regular drug testing to ensure a safe and productive environment. These policies often adhere to federal guidelines, as seen with the U.S. Department of Labor's recommended practices here.

Local companies comply with Pennsylvania state law regarding drug testing. Testing typically occurs pre-employment, randomly, or upon reasonable suspicion. These measures aim to deter drug use and support employee welfare.

Moreover, businesses in Abington partner with local treatment centers to offer employee assistance programs. These programs offer confidential support and resources for addiction issues, aiming to promote long-term recovery and job retention.

Government Efforts with Drug Problems in Abington, PA

The government in Abington, PA, is actively working to address the local drug problem through various initiatives. The Montgomery County Department of Health & Human Services has implemented programs to support those struggling with addiction. These include educational outreach and treatment resources. More information can be found here.

Additionally, state-level efforts by Pennsylvania's Department of Drug and Alcohol Programs work in tandem with local efforts to provide comprehensive support. Grants and partnerships aid communities like Abington. See the state's initiatives here.

Local Drug Busts & News in Abington, PA

Recent drug busts in Abington, PA, highlight ongoing efforts to combat drug distribution in the area. In 2022, the local police department executed several successful raids targeting known drug dens.

These operations often lead to significant seizures of illegal substances and arrests, disrupting supply chains. One notable bust in late 2021 resulted in the confiscation of heroin and methamphetamine valued at over $100,000.

The community also actively participates in drug take-back programs. These events are designed to safely collect and dispose of unused medications, with the aim of preventing misuse and reducing local addiction rates.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Abington, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Caron Pennsylvania

Narberth Police Drug Take Back

Montgomery County Behavioral Health

Pathways to Recovery

Pennsylvania Drug and Alcohol Programs

PA o-drug Epidemic Response

Gateway Rehabilitation Center

Mirmont Treatment Center

Pyramid Healthcare

White Horse Recovery

Drug Testing Near Abington, PA

Wyndmoor, PA

Horsham, PA

Fort Washington, PA

Hatboro, PA

Arcadia University, PA

Oreland, PA

Rockledge, PA

Elkins Park, PA

Bryn Athyn, PA

Bethayres, PA

Wyncote, PA

Glenside, PA

Jenkintown, PA

Willow Grove, PA

Roslyn, PA

Frequently Asked Questions

Customer Reviews